Association of Early Progression Independent of Relapse Activity With Long-term Disability After a First Demyelinating Event in Multiple SclerosisCarmen Tur, Xavier Montalbán, Pere Carbonell‐Mirabent et al.|JAMA Neurology|2022Cited by 278
COVID‐19 in multiple sclerosis patients: susceptibility, severity risk factors and serological responseAna Zabalza, Xavier Montalbán, Simón Cárdenas‐Robledo et al.|European Journal of Neurology|2020Cited by 138
Effect of Changes in MS Diagnostic Criteria Over 25 Years on Time to Treatment and Prognosis in Patients With Clinically Isolated SyndromeMar Tintoré, Xavier Montalbán, Álvaro Cobo‐Calvo et al.|Neurology|2021Cited by 83
Multiple sclerosis management during the COVID-19 pandemicBrandon Moss, Kathryn C. Fitzgerald, Kedar Mahajan et al.|Multiple Sclerosis Journal|2020Cited by 76
The long-term outcomes of CIS patients in the Barcelona inception cohort: Looking back to recognize aggressive MSMar Tintoré, Xavier Montalbán, Georgina Arrambide et al.|Multiple Sclerosis Journal|2019Cited by 72